Despite a surge in investor interest, UK life sciences remains a very niche real estate sub-sector. For the investment proposition to stack-up, the underlying occupier fundamentals must repay the risks associated with investing in an emerging sector. Despite some challenges, we believe this market offers very strong risk-adjusted returns for early-mover investors who can demonstrate a deep understanding of the underlying occupier market and build long-term relationships with key growth tenants.
Want more insights?
Want more insights?
Subscribe to receive the latest private markets perspectives and insights across all sectors directly to your inbox.
Related insights
- Where resilient performance meets stability
- Building the future of innovation
- Real Estate: The Red Thread – Private Markets
- Alternative portfolio: The Red Thread – Private Markets
- US Real Estate Outlook – Edition May 2025
- Asia Pacific Real Estate Outlook – Edition May 2025
- Switzerland Real Estate Outlook – Edition May 2025
- Global Real Estate Outlook – Edition May 2025
- Europe Real Estate Outlook – Edition May 2025
- Green footprints?
Contact us
Make an inquiry
Fill in an inquiry form and leave your details – we’ll be back in touch.
Introducing our leadership team
Meet the members of the team responsible for ÃÛ¶¹ÊÓƵ Asset Management’s strategic direction.
